Profusa (PFSA) Net Income Growth (1y) (2023 - 2026)
Profusa (PFSA) Net Income Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | -30.10% |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 89.28% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 125.69% |
| 10 | Profusa | 66,173.52 | -308,826.48 | - | -311.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -311.28% |
| Dec 31, 2025 | 38.72% |
| Sep 30, 2025 | -24,839.79% |
| Jun 30, 2025 | -1,962.17% |
| Mar 31, 2025 | -36.53% |
| Dec 31, 2024 | -3,666.20% |
| Sep 30, 2024 | 124.82% |
| Jun 30, 2024 | -146.63% |
| Mar 31, 2024 | -286.05% |
| Dec 31, 2023 | -59.06% |
| Sep 30, 2023 | -120.83% |
| Jun 30, 2023 | -29.69% |
| Mar 31, 2023 | -88.11% |